Company Profile

Creative Biosciences Successfully Completed the Acquisition of Helixgen

CreativeBio successfully acquired Helixgen in late March, 2020, marking another milestone in its burgeoning history since 2015. This significant merge will enrich the product lines bilaterally by combining CreativeBio’s strong research & development capability in the field of IVD with Helixgen’s engineering development potential.

2020-03-31

2020-03-11 March Is Colon Cancer Awareness Month

Creative Biosciences is a leading diagnostic company in stool DNA testing for early detection of colorectal cancer in China as well as in the world.

2020-03-11

Colosafe Announces Bravery Appearance at Medical Japan 2020 in Osaka

Colosafe is showcased courageously at Medical Japan 2020 in Osaka right now in the circumstance of the outbreak of COVID-19. Please come to booth# 21-24 at Hall 6 to talk to Dr Yang to get to know how Colosafe can save people’s life in the world where the colorectal cancer is on the rise globally and becoming the 2nd killer among the deadly cancers.

2020-02-28